side effects of glp-1 drugs long term GLP-1 medications, commonly used for type 2 diabetes Updated Ranking and Side Effects

But after menopause, risks are between 20% and 60% higher among women who are overweight or obese

6:7629 [PMC free article: PMC4579574] [PubMed: 26134028] 423

This article explores evidence-based GLP-1 alternatives , including foods, supplements, and lifestyle factors that may help support natural GLP-1 production

Reddys Laboratories, and Lupin are already working on GLP-1-based therapies, preparing for increased demand once patents expire in 2026 in various global markets

Drug companies are cashing in while they can Novo Nordisk, the Danish creator of Ozempic and Wegovy, made $4.8 billion from the drugs in the third quarter of 2023 alone, boosting the economy in Denmark and leading to lower interest rates for ordinary Danes